For several years now, scientists at TU Freiberg have been researching the unique properties of Aplysina aerophoba, a marine sponge species that naturally produces antiviral substances. The substance can inhibit the growth of viruses as well as the entry of viruses into cells. Since the scientists have succeeded in extracting larger amounts of the substance, it could now even be used in clinical trials against the Covid-19 pathogen.
Responsible for the antiviral, antibacterial and antiparasitic effect are the so-called bromtyrosines, which the Aplysina sponge always produces when its tissue has been damaged and it subsequently wants to defend itself against various pathogens.
The natural chemical defence strategy developed by the sponge species during the course of evolution: the breakdown of the connections between the tissue cells leads to a rapid chemical reaction at the injured site.
The product of the reaction, the amino acid derivative bromtyrosine, destroys invading foreign bodies, but also viruses and bacteria immediately. In this way, the active ingredient inhibits protein synthesis and thus the proliferation of RNA viruses - including the coronavirus SARS-CoV-2 - and also prevents viruses from entering the tissue cells.
The Freiberg scientists were able to demonstrate this mechanism of action in pre-clinical studies using tumour cells as an example. In cooperation with the University Hospital Dresden, they did not find any cytotoxic effects on the cells.
"We have succeeded in isolating these bioactive substances in a purely crystalline form, in such quantities (i.e. considerably more than 10 grams) that they are available for immediate clinical investigations against the COVID-19 pathogen," explains Prof. Dr. Hermann Ehrlich from the Biomineralogy and Extreme Biomimetics research group at the TU Bergakademie Freiberg. "In the current situation we are of course open to cooperation with the relevant authorities and institutions," said Ehrlich.
Extracting valuable substance in an environmentally friendly way
In recent years, researchers have been able to extract up to 100% of the valuable bromtyrosine from the sponge thanks to a new method. "We use microwave radiation to isolate and extract the bromine tyrosine from the cells and skeletal fibres of the cultured sponges," explains the head of the Biomineralogy Laboratory at the Institute for Electronic and Sensor Materials.
In cooperation with the Saxon start-up company BromMarin GmbH, Prof. Ehrlich and his team are continuing their research into the ecological method, which involves the cutting off of only part of the sponge under water, thereby completely preserving its regenerative capacity.
The marine horn sponge Aplysina aerophoba
The marine horn sponge Aplysina aerophoba has been growing in the shallow coastal areas of warm seas for more than 500 million years. Today, the largest occurrences of this sponge species are found in the European Mediterranean, especially off the coast of Montenegro, Croatia and Albania.
Since 2014, scientists of the TU Bergakademie Freiberg together with marine biotechnologists of the Institute of Marine Biology in Kotor, Montenegro, have been supervising a 100 square metre sponge breeding facility.
Prof. Dr. Hermann Ehrlich, Phone: +49 3731 39 2867
The Freiberg researchers recently published their results in the journal "Materials Science and Engineering" under the title: Marine biomaterials: Biomimetic and pharmacological potential of cultivated Aplysina aerophoba marine demosponge.
Luisa Rischer | idw - Informationsdienst Wissenschaft
Human skin is an important source of ammonia emissions
27.05.2020 | Max-Planck-Institut für Chemie
Biotechnology: Triggered by light, a novel way to switch on an enzyme
27.05.2020 | Westfälische Wilhelms-Universität Münster
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
27.05.2020 | Earth Sciences
27.05.2020 | Life Sciences
27.05.2020 | Information Technology